Podcasts about benzodiazepines

This episode originally aired as #327 on 5/20/23. It's an oldie but goodie so we are sharing it again! Mental Health is a mounting issue in America today.  Pharma prescriptions are higher than ever before, more people are in therapy than ever before and more than ever, people are searching for alternatives to those methods. On today's episode Jared runs through what he considers to be the foundational things that you should consider to improve your mental health. You will learn about the gut brain connection, deficiencies that impact mental health, the value of breath, sleep, water,  sunshine and more.Products:Precision Probiotic Vital SporesVital 5 Magnesium BisglycinateVital 5 Ultimate Vitality Multi-VitaminBioCoenzymated Active B ComplexVital 5 Omega 3 + AntioxidantsUltra Strength RX Omega 3Sensoril AshwagandhaAnxiety ReleaseVital SleepL-Theanine chewables Additional Information:Episode #164: Psychobiotics - Unique Probiotics for Depression, Anxiety and More Part 1Episode #166: Psychobiotics - Unique Probiotics for Depression Anxiety and More Part 2Episode #306: The Great Debate in Probiotics: Human Strains vs. SporesEpisode #258: Your Magnesium Users GuideEpisode #264: Jen's Story: How One Woman Fought Through Addiction, Mental and Physical Illness to Find Vitality.Episode #265: Sleep! Your Guide to Falling Asleep, Staying Asleep and Deeper and More Restful SleepVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.

Dr. Casey Grover breaks down psychiatric medications and their role in addiction treatment, explaining how different medications work, when they're most appropriate, and which ones to avoid. He provides a practical overview based on his extensive experience treating patients with substance use disorders.• Psychiatric medications get developed through research on brain receptors and undergo rigorous testing before FDA approval• Medications often have "off-label" uses that weren't originally intended but provide benefits in certain situations• Antidepressants like SSRIs and SNRIs serve as the foundation for treating depression in people with addiction• Using non-addictive options like hydroxyzine, clonidine, and buspirone is crucial when treating anxiety in recovery• Trazodone and mirtazapine are preferred for sleep issues over benzodiazepines and "Z-drugs" that can create dependence• ADHD treatment requires careful consideration when patients have stimulant use disorder histories• Benzodiazepines should be avoided when possible as they paradoxically worsen anxiety over time• Medication selection should consider urgency of conditions, past medication responses, and potential side effects• Some psychiatric conditions may improve with therapy allowing medication reduction, while others require long-term treatmentThank you for taking the time to learn about addiction. It's a fight we cannot win without awareness and action. There's still so much we can do to improve how addiction is treated. Together we can make it happen. Remember, treating addiction saves lives.To contact Dr. Grover: ammadeeasy@fastmail.com

Neurobiologist Jamie Zeitzer is an expert on sleep – or, more accurately, an expert on why so many can't sleep. He notes that, ironically, it's often anxiety about sleep that prevents good sleep. In short, we lose sleep over lost sleep. Wearables and other tools can help but only to a point, and medications do not induce natural sleep. Instead, he counsels consistent routines, less stimulation at bedtime, and cognitive behavioral therapy to reduce worry about insomnia. Unfortunately, you can't work harder to get better sleep – you have to learn to relax, Zeitzer tells host Russ Altman on this episode of Stanford Engineering's The Future of Everything podcast.Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to thefutureofeverything@stanford.edu.Episode Reference Links:Stanford Profile: Jamie ZeitzerConnect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / FacebookChapters:(00:00:00) IntroductionRuss Altman introduces guest Jamie Zeitzer, professor of psychiatry and behavioral sciences at Stanford University.(00:03:12) Understanding Circadian RhythmsHow the biological clock regulates sleep and other body functions.(00:04:57) The Mystery of Sleep's PurposeWhat is still unknown about the fundamental need for sleep.(00:06:00) Light and the Circadian ClockThe impact light exposure has on the body's internal sleep timing.(00:08:13) Day and Night Light ContrastThe importance of creating a light-dark contrast for healthy rhythms.(00:11:18) Phones, Screens, and the Blue LightWhether blue light from screen use affects sleep quality.(00:13:49) Defining and Diagnosing Sleep ProblemsHow stress and over-focus on sleep quality worsen insomnia.(00:16:02) Sleep Anxiety and WearablesThe psychological downsides of sleep data from tracking devices.(00:17:14) CBT-I and Rethinking InsomniaMentally reframing sleep with cognitive behavioral therapy for insomnia.(00:21:21) Desynchronized Sleep PatternsStudying student sleep patterns to separate circadian vs. sleep effects.(00:23:49) Shift Work and Circadian MisalignmentThe difficulty of re-aligning circadian clocks in rotating shifts.(00:26:26) Effectiveness of Sleep MedicationsThe various drugs used to promote sleep and their pros and cons.(00:29:46) Circadian “Sleep Cliff” and MelatoninThe brain's “wake zone” before sleep and the limited effects of melatonin.(00:32:52) Do's & Don'ts for Better SleepAdvice for those looking to improve their sleep quality.(00:34:55) Alcohol and Caffeine EffectsHow metabolism influences the effects of alcohol and caffeine on sleep.(00:37:24) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook

Un nouvel épisode du Pharmascope est disponible et on s'attaque cette fois au trouble d'usage d'alcool. Dans cette première partie, Nicolas, Isabelle et une nouvelle invitée discutent du dépistage et de l'évaluation de cette maladie sous diagnostiquée, en plus de réviser la prise en charge du sevrage alcoolique. Les objectifs pour cet épisode sont: Procéder au dépistage du trouble d'usage d'alcool Diagnostiquer un trouble d'usage d'alcool Discuter des bénéfices et des désavantages associés aux principaux traitements pharmacologiques du sevrage alcoolique   Ressources pertinentes en lien avec l'épisode Lignes directrices canadiennes récentes en trouble d'usage d'alcool Wood E, Bright J, Hsu K, et coll. Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder. CMAJ. 2023 Oct 16;195(40):E1364-E1379. Repères canadiens sur l'alcool et la santé : rapport final. Centre canadien sur les dépendances et l'usage de substances. 2023 Guide canadien sur les risques associés à l'usage d'alcool Coalition canadienne pour la santé mentale des personnes pagées. Lignes directrices sur le trouble lié à l'utilisation de l'alcool chez les personnes âgées. 2023. Guide de l'INESSS sur la prise en charge du trouble d'utilisation d'alcool INESSS. Sevrage d'alcool et prévention des rechutes. 2021. US Preventive Services Task Force; Curry SJ, Krist AH, Owens DK, et coll. Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2018 Nov 13;320(18):1899-1909. Mitchell AJ, Bird V, Rizzo M, et coll. Accuracy of one or two simple questions to identify alcohol-use disorder in primary care: a meta-analysis. Br J Gen Pract. 2014 Jul;64(624):e408-18. Bush K, Kivlahan DR, McDonell MB, et coll. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998 Sep 14;158(16):1789-95. Maldonado JR, Sher Y, Das S, et coll. Prospective Validation Study of the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) in Medically Ill Inpatients: A New Scale for the Prediction of Complicated Alcohol Withdrawal Syndrome. Alcohol Alcohol. 2015 Sep;50(5):509-18. Kaner EF, Beyer FR, Muirhead C, et coll. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev. 2018 Feb 24;2(2):CD004148. Amato L, Minozzi S, Vecchi S, Davoli M. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev. 2010 Mar 17;(3):CD005063. Daeppen JB, Gache P, Landry U, et coll. Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial. Arch Intern Med. 2002 May 27;162(10):1117-21. Elholm B, Larsen K, Hornnes N, Zierau F, Becker U. Alcohol withdrawal syndrome: symptom-triggered versus fixed-schedule treatment in an outpatient setting. Alcohol Alcohol. 2011 May-Jun;46(3):318-23. Minozzi S, Amato L, Vecchi S, Davoli M. Anticonvulsants for alcohol withdrawal. Cochrane Database Syst Rev. 2010 Mar 17;(3):CD005064. Airagnes G, Valter R, Ducoutumany G, Vansteene C, Trabut JB, Gorwood P, Dubertret C, Matta J, Charles-Nelson A, Limosin F. Magnesium in the treatment of alcohol withdrawal syndrome: a multicenter randomized controlled trial. Alcohol Alcohol. 2023 May 9;58(3):329-335.

Un nouvel épisode du Pharmascope est maintenant disponible! Dans de ce 138ème épisode, Nicolas, Isabelle et Olivier discutent d'un problème pas reposant : le syndrome des jambes sans repos. Les objectifs pour cet épisode sont : Expliquer la présentation clinique, les critères diagnostics et les facteurs de risque du syndrome des jambes sans repos Conseiller des mesures non-pharmacologiques pour aider les personnes avec un syndrome des jambes sans repos Discuter des bénéfices et des désavantages associés aux principaux traitements pharmacologiques du syndrome des jambes sans repos   Ressources pertinentes en lien avec l'épisode Manconi M, Garcia-Borreguero D, Schormair B, Videnovic A, Berger K, Ferri R, Dauvilliers Y. Restless legs syndrome. Nat Rev Dis Primers. 2021 Nov 3;7(1):80. Trotti LM, Becker LA. Iron for the treatment of restless legs syndrome. Cochrane Database Syst Rev. 2019 Jan 4;1(1):CD007834. Earley CJ, García-Borreguero D, Falone M, Winkelman JW. Clinical Efficacy and Safety of Intravenous Ferric Carboxymaltose for Treatment of Restless Legs Syndrome: A Multicenter, Randomized, Placebo-controlled Clinical Trial. Sleep. 2024 Apr 16:zsae095. Short V, Allen R, Earley CJ, Bahrain H, Rineer S, Kashi K, Gerb J, Auerbach M. A randomized double-blind pilot study to evaluate the efficacy, safety, and tolerability of intravenous iron versus oral iron for the treatment of restless legs syndrome in patients with iron deficiency anemia. Am J Hematol. 2024 Jun;99(6):1077-1083. Wilt TJ, MacDonald R, Ouellette J, Khawaja IS, Rutks I, Butler M, Fink HA. Pharmacologic therapy for primary restless legs syndrome: a systematic review and meta-analysis. JAMA Intern Med. 2013 Apr 8;173(7):496-505. Allen RP, Chen C, Garcia-Borreguero D, Polo O, DuBrava S, Miceli J, Knapp L, Winkelman JW. Comparison of pregabalin with pramipexole for restless legs syndrome. N Engl J Med. 2014 Feb 13;370(7):621-31. Trenkwalder C, Benes H, Grote L, Happe S, Högl B, Mathis J, Saletu-Zyhlarz GM, Kohnen R; CALDIR Study Group. Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trial. Mov Disord. 2007 Apr 15;22(5):696-703. Trenkwalder C, Beneš H, Grote L, García-Borreguero D, Högl B, Hopp M, Bosse B, Oksche A, Reimer K, Winkelmann J, Allen RP, Kohnen R; RELOXYN Study Group. Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension. Lancet Neurol. 2013 Dec;12(12):1141-50. Carlos K, Prado GF, Teixeira CD, Conti C, de Oliveira MM, Prado LB, Carvalho LB. Benzodiazepines for restless legs syndrome. Cochrane Database Syst Rev. 2017 Mar 20;3(3):CD006939. Jadidi A, Rezaei Ashtiani A, Khanmohamadi Hezaveh A, Aghaepour SM. Therapeutic effects of magnesium and vitamin B6 in alleviating the symptoms of restless legs syndrome: a randomized controlled clinical trial. BMC Complement Med Ther. 2022 Dec 31;23(1):1. Wali SO, Abaalkhail B, Alhejaili F, Pandi-Perumal SR. Efficacy of vitamin D replacement therapy in restless legs syndrome: a randomized control trial. Sleep Breath. 2019 Jun;23(2):595-601.

In this episode, we explore the challenges and current guidelines for benzodiazepine use in pregnancy, breastfeeding, and adolescence. When is it appropriate to continue benzodiazepines during pregnancy, and what alternatives should clinicians consider? Faculty: Alexis Ritvo, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1 CME: Understanding Benzodiazepine Prescribing: A Clinician's Guide Consequences of Benzodiazepine Use in Pregnancy, Breastfeeding, and Adolescence

In today's episode of The Root Cause Medicine Podcast, Dr. Kate Kresge sits down with Dr. Ellen Vora to discuss a revolutionary framework for understanding anxiety—not as a disorder, but as a message from the body or soul. They explore the difference between false anxiety, which stems from physiological imbalances like blood sugar crashes, sleep disruption, and inflammation, and true anxiety, which often points to deeper emotional or existential truths. You'll hear them discuss: - Why anxiety is the beginning of an inquiry—not a final diagnosis - The difference between “false” (body-based) and “true” (purpose-driven) anxiety - How nutrient deficiencies and gut imbalances can mimic psychiatric symptoms - The surprising mental health effects of hormonal birth control - How to use food as medicine to support neurotransmitter balance and calm - The dangers of benzodiazepines—and how to taper with the help of functional medicine - The power of psychobiotics, circadian rhythm, and inflammation reduction - Why GABA, inositol, and phosphatidylcholine are key to recovery - How to approach anxiety with both compassion and curiosity

In this episode, we explore benzodiazepine use disorder, distinguishing between physical dependence and addiction while examining practical strategies for safe prescribing. Did you know only 1.5% of benzodiazepine users actually develop a use disorder? Faculty: Alexis Ritvo, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1 CME: Understanding Benzodiazepine Prescribing: A Clinician's Guide Benzodiazepine Use Disorder

In this episode, we explore the dangerous risks of benzodiazepine use, focusing on the potentially lethal combination with opioids, cognitive impairment, increased accident risk, and fall hazards. Did you know that benzodiazepines combined with opioids increase overdose risk fivefold in the first 90 days? Faculty: Alexis Ritvo, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1 CME: Understanding Benzodiazepine Prescribing: A Clinician's Guide Understanding the Major Risks of Benzodiazepine Use

This is not your typical real estate episode. In one of the most raw and vulnerable conversations ever, Chris Arnold shares his harrowing journey through burnout, betrayal, benzo withdrawal, and near-suicide, and how he emerged on the other side with a radically new sense of self. Whether you're thriving or silently struggling, this conversation might be the wake-up call you didn't know you needed.   KEY TAKEAWAYS How high-achieving men often suppress the emotional wounds driving their success The silent formula that's destroying entrepreneurial men from the inside out impact of benzo withdrawal and how it nearly ended Chris's life Why emotional pain lives in the body and what to do about it The controversial but life-saving role ayahuasca played in Chris's recovery RESOURCES/LINKS MENTIONED Ayahuasca TWEETABLES “True leadership begins in your life, and your passion, destiny, calling, and unique contributions from the fact that you wake up every day and you get to do you.”- Chris Arnold “The more we share our story, the less of a hold it has on us.” - Chris Arnold   ABOUT CHRIS ARNOLD  Chris Arnold is a co-founder of The Multipliers Brotherhood and COSA Investments, one of the largest wholesale companies in the DFW Metroplex. He also founded Arnold Elite Realty, a modern boutique brokerage, and created REI Radio, a coaching program that teaches real estate wholesalers how to find motivated sellers through radio. Operating his companies entirely virtually allows him the freedom to work from anywhere, yet he chooses the beautiful Tulum, Mexico, as his base.   CONNECT WITH CHRIS Website: Simplifiers Brotherhood

Dr. Roger McFillin challenges standard treatments that keep patients trapped in fear cycles. He reveals why panic disorder—one of the most common presenting mental health concerns—is HIGHLY treatable without drugs, and provides actionable steps to transform your relationship with anxiety. Discover the fundamental principles that could free you from panic attacks and learn why conventional approaches might be blocking your recovery. This foundational episode delivers the evidence-based perspective needed to understand what's really happening during panic and how to overcome it for good.Dr. Roger McFillin / Radically Genuine WebsiteYouTube @RadicallyGenuineDr. Roger McFillin (@DrMcFillin) / XSubstack | Radically Genuine | Dr. Roger McFillinInstagram @radicallygenuineContact Radically GenuineConscious Clinician CollectivePLEASE SUPPORT OUR PARTNERS15% Off Pure Spectrum CBD (Code: RadicallyGenuine)10% off Lovetuner click here

In this episode, I address two deeply personal listener questions that highlight the complex nature of anxiety and emotional healing in relationships. The first question comes from a listener who has struggled with anxiety for most of their life, recently facing severe limitations due to Generalized Anxiety Disorder and medication changes. We talk about the genetic components of anxiety, the risks of benzodiazepines in older adults, and the importance of advocating for the right care—even if that means seeking new providers or considering higher levels of treatment. The second question dives into the emotional fallout after infidelity. A listener is working to rebuild their marriage after their wife's emotional and physical affairs but finds themselves overwhelmed by anger and trauma in the aftermath. I explore the importance of time, trauma-informed coping strategies, and how rebuilding trust is possible with consistent effort and support. Whether you're dealing with anxiety yourself or navigating complex relationship dynamics, this episode offers validation, practical advice, and hope. Key Discussion Points Question 1: Genetic Anxiety and Benzodiazepines Anxiety can be partially genetic—up to 50% of risk may be inherited. Environmental factors, early life experiences, and chronic stress also play key roles. Long-term anxiety can even change brain structures like the amygdala. Benzodiazepines such as Xanax and Klonopin can be risky for older adults, but abrupt changes in medication are harmful and inappropriate. Importance of finding the right provider—psychiatric care may be more appropriate than primary care in severe cases. Options like partial hospitalization, intensive outpatient programs, or even voluntary hospitalization if suicidal thoughts worsen. Consideration of alternative treatments like TMS, ketamine therapy, EMDR, or comprehensive medical workups. Encouragement and validation that meaningful change is possible—even later in life. Question 2: Healing from Infidelity Emotional and physical infidelity can lead to feelings of inadequacy and intense emotional reactivity. The resurfacing of past wounds during present-day arguments is a trauma response. Healing takes time; both partners must commit to rebuilding trust. Grounding, breathing, and self-regulation tools are essential in emotional moments. Individual therapy and journaling can help process complex feelings and trauma. Couples therapy with a specialist in infidelity recovery can provide structure and support. It's possible to rebuild a stronger relationship—but it takes honest effort from both sides. Timestamps 00:00 – Intro 01:12 – Listener question: Is anxiety genetic? 03:22 – Genetics vs. environment in anxiety development 05:10 – Medication history and benzodiazepine concerns for older adults 08:45 – Advocating for appropriate psychiatric care 12:30 – Suicidal thoughts and higher levels of support 14:50 – Exploring alternative and emerging treatment options 17:15 – Words of encouragement and validation 19:45 – Listener question: Coping with infidelity and feeling inadequate 21:20 – Emotional fallout and trauma from betrayal 24:10 – Regulating emotional responses during arguments 26:00 – The role of time, patience, and couples therapy 28:20 – Journaling and individual processing for long-term healing 31:10 – Rebuilding a stronger relationship after infidelity 33:00 – Closing thoughts and takeaways Resources & Links Website: http://duffthepsych.com Email: duffthepsych@gmail.com YouTube: https://www.youtube.com/@duffthepsych Instagram: https://instagram.com/duffthepsych If today's episode resonated with you, consider leaving a review or sharing it with someone who could use the support. Your stories and questions continue to make this podcast what it is—thank you for being here. Until next time, take care and keep pushing forward. You've got this.

It's a stressful world out there. And one way some people quiet it down is taking medications like Lorazepam, Xanax, or Valium. They're called Benzodiazepines and their use and misuse has become a plotline in the popular TV series The White Lotus and The Pitt. University of British Columbia's clinical assistant professor and addictions medicine specialist Dr. Paxton Bach explains the benefits and risks of taking benzos. For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.

Benzodiazepines: Risks, Origins, and Prescribing

Story at-a-glance Benzodiazepines (benzos), the go-to treatment for anxiety, cause several issues, especially for the elderly, like cognitive impairment, lightheadedness, poor coordination, and fatigue, all of which increase the risk of accidents and falls When used for the correct type of anxiety and combined with other therapeutic interventions, benzodiazepines can greatly help anxiety Unfortunately, the fast-paced, insurance-driven healthcare system often leads to rushed 15-minute appointments, preventing doctors from properly evaluating whether benzodiazepines are right for a patient As a result, many people who should not be on benzodiazepines end up being put on them for years, if not decades, without proper oversight or treatment of their underlying illness One of the biggest problems with benzodiazepines is how quickly they create a physical dependence, leading to widespread addiction. They can also harm fetuses, worsen symptoms like insomnia and anxiety, and, in the worst cases, lead to deadly overdoses, especially when combined with opioids

In this episode, we review the high-yield topic of ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Benzodiazepines⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Neurology section.Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbullets

In this episode, we explore the pharmacological management of agitation in emergency settings, focusing on benzodiazepines and the novel medication dexmedetomidine. Did you know there's now a sublingual option that works through an entirely different mechanism than traditional anti-agitation medications? Faculty: Scott Zeller, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: The Psychopharmacology of Agitation: Managing Behavioral Emergencies The Role of Benzodiazepines and Dexmedetomidine in Managing Agitation

In this engaging conversation on the Crazy Wisdom podcast, Stewart Alsop talks with neurologist Brian Ahuja about his work in intraoperative neurophysiological monitoring, the intricate science of brainwave patterns, and the philosophical implications of advancing technology. From the practical applications of neuromonitoring in surgery to broader topics like transhumanism, informed consent, and the integration of technology in medicine, the discussion offers a thoughtful exploration of the intersections between science, ethics, and human progress. Brian shares his views on AI, the medical field's challenges, and the trade-offs inherent in technological advancement. To follow Brian's insights and updates, you can find him on Twitter at @BrianAhuja.Check out this GPT we trained on the conversation!Timestamps00:00 Introduction to the Crazy Wisdom Podcast00:21 Understanding Intraoperative Neurophysiological Monitoring00:59 Exploring Brainwaves: Alpha, Beta, Theta, and Gamma03:25 The Impact of Alcohol and Benzodiazepines on Sleep07:17 The Evolution of Remote Neurophysiological Monitoring09:19 Transhumanism and the Future of Human-Machine Integration16:34 Informed Consent in Medical Procedures18:46 The Intersection of Technology and Medicine24:37 Remote Medical Oversight25:59 Real-Time Monitoring Challenges28:00 The Business of Medicine29:41 Medical Legal Concerns32:10 Alternative Medical Practices36:22 Philosophy of Mind and AI43:47 Advancements in Medical Technology48:55 Conclusion and Contact InformationKey InsightsIntraoperative Neurological Monitoring: Brian Ahuja introduced the specialized field of intraoperative neurophysiological monitoring, which uses techniques like EEG and EMG to protect patients during surgeries by continuously tracking brain and nerve activity. This proactive measure reduces the risk of severe complications like paralysis, showcasing the critical intersection of technology and patient safety.Brainwave Categories and Their Significance: The conversation provided an overview of brainwave patterns—alpha, beta, theta, delta, and gamma—and their connections to various mental and physical states. For instance, alpha waves correspond to conscious relaxation, while theta waves are linked to deeper relaxation or meditative states. These insights help demystify the complex language of neurophysiology.Transhumanism and the Cyborg Argument: Ahuja argued that humans are already "cyborgs" in a functional sense, given our reliance on smartphones as extensions of our minds. This segued into a discussion about the philosophical and practical implications of transhumanism, such as brain-computer interfaces like Neuralink and their potential to reshape human capabilities and interactions.Challenges of Medical Technology Integration: The hype surrounding medical technology advancements, particularly AI and machine learning, was critically examined. Ahuja highlighted concerns over inflated claims, such as AI outperforming human doctors, and stressed the need for grounded, evidence-based integration of these tools into healthcare.Philosophy of Mind and Consciousness: A recurring theme was the nature of consciousness and its central role in both neurology and AI research. The unresolved "hard problem of consciousness" raises ethical and philosophical questions about the implications of mimicking or enhancing human cognition through technology.Trade-offs in Technological Progress: Ahuja emphasized that no technological advancement is without trade-offs. While tools like CRISPR and mRNA therapies hold transformative potential, they come with risks like unintended consequences, such as horizontal gene transfer, and the ethical dilemmas of their application.Human Element in Medicine: The conversation underscored the importance of human connection in medical practice, particularly in neurology, where patients often face chronic and emotionally taxing conditions. Ahuja's reflections on the pitfalls of bureaucracy, private equity in healthcare, and the overemphasis on defensive medicine highlighted the critical need to prioritize patient-centered care in an increasingly technological and administrative landscape.

Julia Britz is a licensed naturopathic doctor who received her training from Bastyr University in San Diego, CA. She specializes in supporting people who are struggling with mental health issues such as OCD, disorders eating and psychiatric medication tapering. Her passion for working with individuals suffering from these lonely conditions is that she too was a “hopeless case”, but got better.Dismissed by doctors, she was told over and over there was nothing else she could try beyond pharmacotherapy, and so was inspired to create myocddiary.com, a site dedicated to documenting the daily life of OCD and related disorders. Through this project and holistic therapies, she found new levels of wellness, and in 2014 did a TED talk called “MyOCDdiary: an imperfect story.” She utilizes natural and integrative modalities including targeted amino acid therapy, peptide therapy, micronutrient therapy, bioresonance, botanical medicine and epigenetic analysis. Most recently she was the director of naturopathic medicine at Alternative to a meds Center in Arizona and now practices telemedicine. SHOWNOTES:

I am thrilled to have Dr. Olivera Bogunovic and Holly Hardman with me on the show today. Dr. Bogunovic is an assistant professor of psychiatry at Harvard Medical School and the medical director of the alcohol, drug, and addiction outpatient program at the McLean Hospital, and Holly directed the documentary As Prescribed. In today's discussion, we dive into the ongoing benzodiazepine crisis in the United States, with over 92 million prescriptions written each year for medications like Ativan, Valium, Xanax, and Klonopin. We discuss the origin of those drugs in the 1970s as treatments for anxiety and how they lead to tremendous physical dependency. Holly shares her experience with the neurological effects she suffered after long-term use of Klonopin, and we examine challenges in psychiatric care, the need for informed consent, and the impact of social media. We also cover the role of lifestyle, the need for psychotherapy and psychosocial support, and the significance of hope. This conversation is truly invaluable! Given how frequently benzodiazepines get prescribed, everyone must understand their associated risks and considerations. IN THIS EPISODE YOU WILL LEARN: How prescribing practices have evolved over the last two decades The significant consequences older adults face when they suddenly stop using benzodiazepines  Holly shares how doctors misinformed her when she began taking Klonopin.  Holly describes the benzodiazepine-induced symptoms and cognitive issues she experienced Why people must get informed about the long-term effects of benzodiazepines when consenting to take them How benzodiazepines work in the body and impact the brain Why benzodiazepines are ineffective when used long-term for insomnia The challenges certain people face when accessing psychiatric care What is BIND, and what are its symptoms? The significance of diet and holistic approaches for managing mental health and why community support is essential in the recovery process Why As Prescribed is an educational documentary for everyone Connect with Cynthia Thurlow   Follow on Twitter Instagram LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Connect with Dr. Olivera Bogunovic The McLean Hospital (in Boston) The documentary, As Prescribed, is available in the United States and Canada on Prime Video, Apple, Kanopy, Tubi, and Google.

Anxiety can seep into our lives like an uninvited guest, disrupting our relationships, altering our moods, and even impacting our physical health. The struggle to recognize and address the roots of this pervasive issue often leaves us feeling overwhelmed and helpless. What if we could reframe our understanding of anxiety, seeing it not as a problem to be suppressed, but as a messenger of deeper, underlying issues? Could this shift in perspective transform not only our personal well-being but also our interpersonal connections? In this episode, we dive deep into the nuances of anxiety, exploring its complex relationship with our bodies, minds, and interactions with others. We discuss practical strategies for setting personal limits to prevent burnout, share insights from groundbreaking research on anxiety and trauma, and introduce step-by-step algorithms that empower you to uncover and heal root causes. You'll discover how integrating biological and psychological knowledge can lead to a more holistic approach to mental health, paving the way for healthier, more fulfilling relationships. Tune in to learn how you can turn your symptoms into powerful access points for healing and personal growth. Nicole Cain, ND, MA, is a pioneer in integrative approaches for mental and emotional wellness. With a degree in clinical psychology, training in EMDR, and being licensed as a naturopathic physician in the state of Arizona, her approach to mental health is multidisciplinary: medical, psychological, and holistic. Check out the transcript of this episode on Dr. Jessica Higgin's website. In this episode 08:03 Can anxiety be healed or just managed? 12:34 How medications like SSRIs and Benzodiazepines can impact relationships. 21:45 How trauma triggers persistent protective responses. 25:06 High-functioning individuals often mask internal struggles. 32:17 How understanding anxiety as data can transform healing and relationships. 36:48 How emotional adaptations from trauma protect us but can also cause issues. 40:08 Identifying root causes rather than just treating symptoms. 46:20 Expert guidance for calming the nervous system and optimizing health recovery. 55:49 Reflecting growth in relationships: Navigating subjective feedback and personal reactions. Mentioned Panic Proof: The New Holistic Solution to End Your Anxiety Forever (*Amazon Affiliate link) (book) Relationship Map To Happy, Lasting Love ERP 423: How to Transcend Trauma (And the Effects Experience in Relationship) — An Interview with Dr. Frank Anderson Connect with Dr. Nicole Cain Websites: drnicolecain.com Facebook: facebook.com/DrNicoleCain YouTube: youtube.com/channel/UCe-hcFYhi5QMmXcR_kNippQ Instagram: instagram.com/drnicolecain Podcast: podcasts.apple.com/us/podcast/holistic-inner-balance-natural-mental-health-podcast/id1506869161 | drnicolecain.com/podcast Pinterest: pinterest.com/drnicolecain Connect with Dr. Jessica Higgins Facebook: facebook.com/EmpoweredRelationship  Instagram: instagram.com/drjessicahiggins  Podcast: drjessicahiggins.com/podcasts/ Pinterest: pinterest.com/EmpowerRelation  LinkedIn: linkedin.com/in/drjessicahiggins  Twitter: @DrJessHiggins  Website: drjessicahiggins.com   Email: jessica@drjessicahiggins.com If you have a topic you would like me to discuss, please contact me by clicking on the “Ask Dr. Jessica Higgins” button here.  Thank you so much for your interest in improving your relationship.  Also, I would so appreciate your honest rating and review. Please leave a review by clicking here.  Thank you!   *With Amazon Affiliate Links, I may earn a few cents from Amazon, if you purchase the book from this link.

In this interview with Dr. Bret Scher, Dr. Mark Horowitz, a leading clinician and researcher in anti-depressant withdrawal and de-prescribing, delves into the complex world of de-prescribing anti-depressants. Dr. Horowitz shares his personal journey with antidepressant withdrawal, which led him to dedicate his career to understanding safe tapering practices. He discusses the challenges that patients face when coming off medications, the withdrawal effects often mistaken for relapses, and how the current psychiatric guidelines may fall short in helping people safely taper. Dr. Horowitz emphasizes the importance of individualized tapering plans and the need for slower, more gradual reductions in medication, challenging the traditional approach of quick tapers over a few weeks. *Key Topics Covered* • The difference between withdrawal symptoms and relapse • The effects of long-term antidepressant use • Dr. Horowitz's personal experience with tapering off Lexapro • The role of clinicians and peer support in the de-prescribing process *Experts Featured* Dr. Mark Horowitz X: @markhoro https://markhorowitz.org/ Resources: Safe tapering resources: https://www.outro.com/ _The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs (The Maudsley Prescribing Guidelines Series)_ https://www.amazon.com/Maudsley-Guidelines-prescribing-Prescribing/dp/111982298X Metabolic Mind's Families & Peers page: https://www.metabolicmind.org/families-and-peers Clinician Directory: https://www.diagnosisdiet.com/directory Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry. Learn more about metabolic psychiatry and find helpful resources at https://metabolicmind.org/ About us: Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them. Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications. #MetabolicMind #MetabolicNeuroscience #KetogenicMetabolicTherapy #NutritionalKetosis#AlternativeTreatment#PsychiatricMedication#KetogenicTherapy #Tapering#Deprescribing

In this episode, we explore the complex relationship between benzodiazepine use and suicide risk, examining a groundbreaking French study that challenges our understanding of this connection. Is our go-to anxiety treatment potentially increasing suicide risk? Faculty: Paul Zarkowski, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 57 Risk for Suicide Attempts and Suicide Associated With Benzodiazepines

#192 In this episode of 'Chemistry for Your Life,' hosts Melissa and Jam introduce special guest Claire Caballero, a pharmacology and neuroscience PhD student, to discuss how antidepressants work. Claire explains the role of neurotransmitters like serotonin, dopamine, and GABA in mental health, the mechanisms of various antidepressants such as SSRIs, tricyclic antidepressants, and monoamine oxidase inhibitors, and touches on the effects and side effects of drugs like Wellbutrin. The episode provides an insightful look at the chemistry and neuroscience behind how these medications help manage depression and anxiety. 00:00 Introduction and Special Guest Announcement 00:52 Meet Claire: Our Expert in Pharmacology and Neuroscience 01:32 Understanding Pharmacology and Neurotransmission 05:16 The Role of Neurotransmitters in Anxiety and Depression 14:16 Deep Dive into Neurotransmitters: GABA, Dopamine, and Serotonin 17:10 Exploring the Mechanisms of Depression and Anxiety 22:21 Ready to Learn About Antidepressant Drugs? 33:20 Understanding SSRIs and Their Uses 34:14 How SSRIs Work in the Brain 36:23 Challenges and Side Effects of SSRIs 43:08 Exploring Tricyclic Antidepressants 48:35 Monoamine Oxidase Inhibitors: The First Antidepressants 54:59 Benzodiazepines: Uses and Risks 01:00:01 Other Notable Drugs: Bupropion and Beta Blockers 01:05:07 Conclusion and Final Thoughts   References from this episode: https://www.ncbi.nlm.nih.gov/books/NBK554406/ https://www.ncbi.nlm.nih.gov/books/NBK557791/ https://www.ncbi.nlm.nih.gov/books/NBK539848/ https://www.ncbi.nlm.nih.gov/books/NBK470159/#:~:text=Benzodiazepines%20are%20effective%20for%20sedation,potential%20to%20develop%20physical%20dependence. https://www.nami.org/about-mental-illness/mental-health-conditions/anxiety-disorders/#:~:text=Anxiety%20disorders%20are%20the%20most,develop%20symptoms%20before%20age%2021. https://mhanational.org/conditions/depression#:~:text=Major%20depression%20is%20one%20of,are%20affected%20by%20major%20depression. https://www.cdc.gov/nchs/products/databriefs/db377.htm https://www.ncbi.nlm.nih.gov/books/NBK470212/ https://www.jneurosci.org/content/28/28/7040 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303399/ https://www.ncbi.nlm.nih.gov/books/NBK551683/#:~:text=Anxiety%20disorders%20such%20as%20panic,with%20decreased%20levels%20of%20GABA. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684250/#:~:text=Neuroendocrine%20and%20Neurotransmitter%20Pathways&text=Well%2Ddocumented%20anxiolytic%20and%20antidepressant,of%20mood%20and%20anxiety%20disorders. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950973/#:~:text=The%20monoamine%2Ddeficiency%20theory%20posits,in%20the%20central%20nervous%20system. https://www.health.harvard.edu/depression/depression-chemicals-and-communication https://www.ncbi.nlm.nih.gov/books/NBK539894/ https://www.sciencedirect.com/science/article/pii/S1476179306700246?via%3Dihub https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610616/ We want to give a special thanks to Bri McAllister for illustrating molecules for some episodes! Please go check out Bri's art, follow and support her at entr0pic.artstation.com and @McAllisterBri on twitter!   Thanks to our monthly supporters Scott B Jessie Reder Ciara Linville J0HNTR0Y Jeannette Napoleon Cullyn R Erica Bee Elizabeth P Sarah Moar Rachel Reina Letila Katrina Barnum-Huckins Suzanne Phillips Venus Rebholz Lyn Stubblefield Jacob Taber Brian Kimball Emerson Woodhall Kristina Gotfredsen Timothy Parker Steven Boyles Chris Skupien Chelsea B Bri McAllister Avishai Barnoy Hunter Reardon ★ Support this podcast on Patreon ★ ★ Buy Podcast Merch and Apparel ★ Check out our website at chemforyourlife.com Watch our episodes on YouTube Find us on Instagram, Twitter, and Facebook @ChemForYourLife

In this Healthed lecture, Dr Adam Straub addresses benzo dependency with real-world advice and evidence-based recommendations. From conversation starters to practical withdrawal plans, Dr Straub will improve GPs' confidence in managing this very complex issue in the primary care setting. See omnystudio.com/listener for privacy information.

Nancy Chia from the OPTICS team is back for another psychiatric pharmacy care conversation. This time we focus in on the role of benzodiazepines for treating anxiety disorders. We touch briefly on the characteristics of some common anxiety disorders and then take a closer look at the reasons why benzodiazepines are a preferred treatment option for their acute symptoms. We also examine the downsides of benzodiazepine use, special concerns in the corrections environment, ideal therapeutic timeframes, treatment alternatives and more. For More About the OPTICS Clinical Pharmacy Team: www.diamondpharmacy.com/clinical-services

Dr. Mark Horowitz, a Clinical Research Fellow in Psychiatry from the UK and co-author of “The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs,” delves into the complexities of deprescribing psychiatric medications such as antidepressants, benzodiazepines, and sleep aids. Dr. Horowitz outlines the origins and importance of the deprescribing movement, explaining how polypharmacy and overprescription have necessitated a careful approach to reducing medication loads safely. He discusses the physiological and withdrawal challenges faced by patients on long-term psychiatric medication, emphasizing the vital role of slow and individualized tapering processes. He covers the substantial influence of pharmaceutical companies on prescription guidelines in the US compared to the UK, shedding light on the differences in medication usage and prescribing cultures. Dr. Horowitz also debunks the chemical imbalance theory of depression, arguing for a more nuanced understanding of mental health issues and their treatment. He introduces Outro, a new clinic founded by Dr. Horowitz in California, aimed at supporting individuals through the deprescribing process.

Dr. Hoffman continues his conversation with Dr. Mark Horowitz, co-author of "The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs."

In this episode Ryan interviews Dr. Alex Krotulski PhD from the Center for Forensic Science Research and Education. Together take a look at trends in novel opioids, benzodiazepines, stimulants, hallucinogens, synthetic cannabinoids, and "hemp products" that are showing up in your patients, drug products, and fatal overdoses. The conversation takes places around the Center for Forensic Science Research and Education quarterly report on Novel Psychoactive Substances found in patients and drug products. The episode starts with a discussion of the novel benzodiazepines market, highlighting bromazolam and how long it may remain in the market. Then they discuss the opioids highlighting where we are seeing carfentanil, what is happening with Para Fluorofentanyl, and other super potent opioids emergening (such as  N -pyrrolidino etonitazene). After a quick discussion of synthetic cathinone's and PCP/ketamine derivatives they jump to synthetic cannabinoids, examining the history of brodifacoum contamination and how regulation has led to market changes.  Resourceshttps://www.cfsre.org/Quarterly report  discussed on this episodeMore on Dr. KrotulskiPoster from Dr. Kortulksi on naming conventions for NPS Time stamps to jump to any portion of the episode you want to revisitIntroduction-5:00-32:5006:30-25:16- Discussion CSFRE mission, history of NPS reports, and other available reports25:14- "Miscellaneous drugs: Furanyl UF17, medetomidine"28:15- Difference between GC/MS and LCqTOFNovel Benzodiazepines- 32:50Novel Opioids-43:00Stimulants and hallucinogens- 1:01:43Synthetic cannabinoids- 1:07:40Novel psychedelics markets, hemp products, phenibut, tianeptine, and kratom-1:25:12

Melissa Bond is a narrative journalist, poet, and matriarch of Salt Lake City's Slam Scene. The Salt Lake Tribune and the New York Post have both done features on Bond's book Blood Orange Night, her memoir about becoming dependent upon and then withdrawing from Benzodiazepines. Blood Orange Night was published by Simon & Schuster in June 2022 and was selected by the New York Times as one of the best audiobooks of 2022. Bond has been featured on PBS Story in the Public Square, Radio West, the podcasts Risk!, Endeavors, Psychology Unplugged, The New York Times  Podcasts, RadioWest and Moms Don't Have Time to Read Books. Listen in to hear Melissa share: How a very common medical prescription for insomnia led to full physical dependence on benzodiazepines that led to her rapid physical and mental downward spiral How she was able to begin to put together the pieces around her unforeseen medication dependence after narrowly escaping harming herself and her daughter in a fall Her discovery that her myriad of strange physical and mental health symptoms were actually her going through medication withdrawal every single day Her decision to confront the doctor who massively overprescribed benzodiazepines to her How the Benzo Harmed Community relates differently to common terminology around addiction  How the “shadow of shame” impacts people's recoveries from substance use, substance dependence, and substance abuse Her advice to moms who are mentally or physically suffering with the demands of motherhood and how they can get help from medical professionals in the most safe and trusting way Links mentioned: Connect with Melissa: www.melissaabond.com Melissa's Book: Blood Orange Night Melissa on Instagram Melissa on Facebook We love the sponsors that make this show possible! You can always find all the special deals and codes for all our current sponsors on our website: https://shamelessmom.com/sponsor Interested in becoming a sponsor of the Shameless Mom Academy? Email our sales team at sales@adalystmedia.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Contributor: Aaron Lessen MD Educational Pearls: Lorazepam (Ativan) is dosed at 0.1 mg/kg up to a maximum of 4 mg in status epilepticus Some ED protocols only give 2 mg initially The maximum recommended dose of levetiracetam (Keppra) is 60 mg/kg or 4.5 g In one retrospective study, only 50% of patients received the correct dose of lorazepam For levetiracetam, it was only 35% of patients Underdosing leads to complications Higher rates of intubations More likely to progress to refractory status epilepticus References 1. Cetnarowski A, Cunningham B, Mullen C, Fowler M. Evaluation of intravenous lorazepam dosing strategies and the incidence of refractory status epilepticus. Epilepsy Res. 2023;190(November 2022):107067. doi:10.1016/j.eplepsyres.2022.107067 2. Sathe AG, Tillman H, Coles LD, et al. Underdosing of Benzodiazepines in Patients With Status Epilepticus Enrolled in Established Status Epilepticus Treatment Trial. Acad Emerg Med. 2019;26(8):940-943. doi:10.1111/acem.13811 Summarized by Jorge Chalit, OMSII | Edited by Meg Joyce & Jorge Chalit  

In this conversation, Rav Arora and Dr. Matt Johnson discuss the current state of mainstream pharmaceutical solutions for mental health issues such as ADHD, depression, and anxiety. They highlight the limitations and potential harms of traditional medications, including overuse of ADHD stimulant medications and the simplistic narrative of depression being caused by low serotonin levels. They also discuss the importance of considering the complexity of mental health disorders and the need for a holistic approach that includes therapy and addressing root causes. They touch on the potential benefits of psychedelic therapy as a complementary tool in the treatment of mental health issues. The conversation explores the lack of long-term evidence for the effectiveness of medications in treating mental health disorders. Psychopharmacology, the field of medication for mental health, faces challenges in finding effective treatments for complex psychological problems. Medications like SSRIs and benzodiazepines have limitations in terms of long-term efficacy and side effects. The use of psychedelics, such as ketamine, has shown promise in providing immediate relief for depression and anxiety. However, the field of psychopharmacology still lacks major breakthroughs and relies on medications that may not fully address the complexity of psychological issues. The development of non-psychedelic compounds that mimic the effects of psychedelics without the visionary experience may not be as effective. The conversation highlights the need for innovative approaches to mental health treatment.Takeaways* Mainstream pharmaceutical solutions for mental health issues like ADHD, depression, and anxiety have limitations and potential harms.* Overuse of ADHD stimulant medications is a concern, and the narrative of depression being caused by low serotonin levels is overly simplistic.* Mental health disorders are complex and require a holistic approach that includes therapy and addressing root causes.* Psychedelic therapy shows promise as a complementary tool in the treatment of mental health issues, offering the potential for long-term benefits and addressing deep-seated trauma. There is a lack of long-term evidence for the effectiveness of medications in treating mental health disorders.* Individual experiences with antidepressants vary, with some reporting significant benefits while others do not.* The influence of pharmaceutical companies on prescribing practices and the need for better regulation and transparency in the industry are important considerations.* Psychotherapy, such as cognitive behavioral therapy, can be highly effective in treating anxiety disorders and depression.* Benzodiazepines are commonly prescribed for anxiety but can have negative long-term effects and should be used with caution. Psychopharmacology struggles to find effective treatments for complex psychological problems.* Medications like SSRIs and benzodiazepines have limitations in terms of long-term efficacy and side effects.* Psychedelics, such as ketamine, show promise in providing immediate relief for depression and anxiety.* The field of psychopharmacology lacks major breakthroughs and innovative approaches to mental health treatment.* Non-psychedelic compounds that mimic the effects of psychedelics without the visionary experience may not be as effective.Titles* The Importance of a Holistic Approach to Mental Health* The Potential of Psychedelic Therapy as a Complementary Tool The Varying Experiences with Antidepressants* The Cautionary Use of Benzodiazepines for Anxiety The Limitations of Medications in Mental Health Treatment* Non-Psychedelic Compounds: Can They Mimic the Effects of Psychedelics?Sound Bites* "There are major issues with some traditional medications"* "The narrative of depression being caused by low serotonin is overly simplistic"* "Psychedelic therapy offers the potential for long-term benefits"* "What you really want are studies that have randomized people and maintain that randomization and that blind for those long-term outcomes."* "SSRIs were the most important part of it, not the psychedelics."* "Raising just a point or two on one of the standard depression inventories, every point counts, man."* "Nothing compares to the GABA-Urgic drugs because they have their primary button on just relaxing your motor system."* "Psychopharmacology medications for the mind don't seem to work the same way as other classes of medicine."* "There's a real danger associated with being on benzodiazepines chronically."‘Chapters00:00 Introduction and Background09:20 Mainstream Pharmaceutical Solutions for Mental Health32:00 Exploring the Root Causes of Mental Health Disorders46:30 The Limitations of Psychopharmacology57:43 The Complexity of Mental Health and Treatment01:08 Debunking the Serotonin Model of Depression01:29 The Limitations of Medications for Anxiety01:58 Closing Remarks and Future Directions This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.illusionconsensus.com/subscribe

In this episode Ben Scher talks to Dr Adam Bakker, Professor Michael Liebrenz and Dr Alexander Smith about their commentary in response to a previous paper by Domzaridou and colleages (2023). They discuss the complexities of providing treatment for people who use, and are prescribed, opiates, opiate agonist medications and benzodiazepines. They talk about using a combination of medical and non-medical treatments when working with people who use benzodiazepines as well as the research needed to bring clarity to this pressing clinical issue."This population is notoriously difficult to engage, but we should go the extra mile to retain them in treatment because of this high mortality."Original Article: Comment on Domzaridou et al.: Recognising the complexities of co-prescriptions and lifestyle factors in opioid agonist treatment by Adam Bakker and colleagues. Published in Addiction (2024).The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information. Hosted on Acast. See acast.com/privacy for more information.

In this episode, MS3 Bilal Rana will go over the most pertinent information regarding barbiturates and benzodiazepines, a topic that can be more confusing than it needs to be!

Seizures are part of the bread and butter in emergency medicine. Most of the time when these patients arrive in the ED, the seizing has stopped and there isn't much else for us to do. But in the cases where they seizures don't stop or when the patient has multiple seizures, do you know what meds to give and how much? How about second line? Third? Perhaps, even fourth line? In this episode Dr. Rod Fontenette goes over the latest in seizure management when first line benzos don't work, the appropriate dosing of those meds, and what to do in certain patient populations.

In this solo episode Craig shares his current thoughts on MDMA medicalization, sleep meds, ADD, motivation vs self-discipline, benzos, how long to stay on psych meds, a change and a proposed addition to his top 10 med list, borderline vs bipolar, and marriage.Bringing Therapy into Med Management-- An intensive training with Dr.  Hhttps://www.craigheacockmd.com/training/BFTA on IG @backfromtheabysspodcasthttps://www.instagram.com/backfromtheabysspodcast/BFTA/ Dr. Hhttps://www.craigheacockmd.com/podcast-page/

Join Kristin as she talks with Dr Mark Horowitz about how to deprescribe psychotropics like antidepressants, what is known about the causes of depression, what evidence is behind the antidepressants commonly used, what the symptoms of antidepressant withdrawal look like and the origins of the phrase "it's Bedlam here." The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs are available for purchase here:  https://www.wiley.com/en-us/The+Maudsley+Deprescribing+Guidelines%3A+Antidepressants%2C+Benzodiazepines%2C+Gabapentinoids+and+Z+drugs-p-9781119823025  This podcast has been released to co-incide with MedsAware which is SHPA's Deprescribing Action Week, 18-24 March 2024 - find out more here: https://www.shpa.org.au/news-advocacy/MedsAware   

This man took the very potent benzo, Phenazepam, without a scale and all hell breaks loose...

Dr Mark Horowitz discusses why psychiatric medication has turned out to be far harder to stop than any one expected. For Mark, this is as much a personal as well as a professional interest. For as a patient, at one point he was taking five different psychiatric drugs. Ironically, although Mark was working in London at the Institute of Psychiatry, he found the mostly useful information about deprescribing came -  not from the medical profession - but from peer support websites. This experience has driven his research and interest in safely stopping psychiatric medication. He, along with Professor David Taylor, has just written a new handbook The Maudsley Deprescribing Guidelines, providing step-by-step instructions on how to effectively stop all commonly used antidepressants, benzodiazepines, gabapentinoids and z-drugs. One of the key findings from this work, is that it is essential to taper off the drugs much more slowly than patients have previously been advised. And perhaps most surprising of all, is  how a small amount of medication can have a completely disproportionate effect. In some cases, a 1mg dose can have nearly half the effect of a 20 mg dose, which means patients may have to taper far more gradually as they move down to smaller and smaller amounts of a drug. A process that may need to take months or even years. The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs (The Maudsley Prescribing Guidelines Series) by Mark Horowitz and David Taylor, published by Wiley-Blackwell will be available from 15 February 2024.   The host of the podcast, Liz Tucker is an award winning medical journalist and former BBC producer and director.  You can follow Liz on Twitter at https://twitter.com/lizctucker and read her Substack newsletter about the podcast at https://liztucker.substack.com If you would like to support this podcast you can do so at patreon.com/whatyourgpdoesnttellyou or via PayPal at https://www.patreon.com/WhatYourGPDoesntTellYou

Brandon Daniel - Cop Killer - Full Police Interrogation Daniel, now 32, is on death row for the murder of an Austin police officer in 2012. AUSTIN – The Texas Court of Criminal Appeals has upheld the death sentence for a man convicted of fatally shooting an Austin police officer. APD Officer Jaime Padron responded to the Walmart near Interstate 35 and Parmer lane around 2:30 a.m. April 6, 2012 for a reported shoplifter. Brandon Daniel struggled with Padron before he shot and killed the officer. Daniel, now 32, was found guilty in February 2014 and sentenced to death. To whom it may concern, My name is Brandon Daniel, and I am writing this letter to you from prison. With police brutality once again in the news, and legal reform a hot topic of discussion, I'm writing to tell you about my legal case, in the hope that I might be able to spread awareness about a common but little known condition that is responsible for sending others to prison, and perhaps to leverage your platform to gain support as well. My case involves the class of anti-anxiety medication called benzodiazepines, and it is one of the clearest examples of something called Paradoxical Reaction. I am hoping that you can help me. Let me fill you in on my story. First, my background is relevant because it demonstrates that the event that led to my being here was not part of a pattern of behavior. I have no violence in my past, no felonies. I was a software engineer, I'm college educated, and I'm from a normal, middle-class home. Everything that happened that night was completely atypical and out of character. The event took place at Walmart, so it was all captured on surveillance videos. You can see me stumble around the store for twenty minutes, dropping items and running into displays. I was clearly disoriented. A police officer was called, and he confronted me, tackled me, and in the chaos of the moment I shot and killed him. The video shows how hectic the situation was, it clearly was not a thought out and intentional act. It took place in the span of 10 seconds. Subsequent blood tests revealed that I had 11 times the therapeutic dose of Xanax in my system, and these tests were taken seven hours after the event. With a half life of eleven hours, it is reasonable to assume that the amount of Xanax in my blood that night was extraordinarily high. Plus, as I later discovered, Asians metabolize Benzos faster than other populations and it stays in their systems longer. I am of Asian descent. In addition to all of this, I was interviewed by police immediately after the event, while I was still highly impaired from the medication. Again, this interview was captured on video, and one can clearly see that I am suffering from the classic symptoms of Benzodiazepines. I had amnesia, stating several times that I couldn't even remember what day or time it was. I was confabulating, giving different accounts of what happened, none of which turned out to be accurate. And I was experiencing chemical submission, complying with the detectives leading questions against my best interest. All of these are common side-effects of the Benzodiazepine class of pharmaceuticals, which includes the date rape drug “roofies.” This aspect of my case sets me apart from other similar cases, I believe. My confused statements provide a window into my state of mind at the time, while in many other incidents we can only wonder what is going on in their mind. After all of this, while awaiting trial, the jailhouse doctors put me on a cocktail of antidepressants: Zoloft, Celexa, Remeron, etc. During this time, I had several suicide attempts and I spent most of the time in observation cells, nearly catatonic. It is my belief that this common, secondary use of pharmaceuticals to medicate inmates awaiting trial, renders them complacent and fairly useless when it comes to contributing to their defense. This results in inmates who are resigned to their fate, able to be easily railroaded by the legal system, regardless of the merits of their case. Since most people who are first entering jail are, understandably, depressed, they are all too willing to accept this ‘treatment'

In this edition of Heard online we look at claims made about Benzodiazepine use and Alzheimer's disease. We find that symptoms of the this condition can be seen decades before a diagnosis is made, symptoms that Benzodiazepines are often prescribed for.  Would you like a roadmap from Insomnia to immunity? Download using below link. https://www.thesleepcoachschool.com/h... — Would you like to work with one of our certified sleep coach? Awesome! Here are some great options: The Insomnia Immunity Group Coaching Program.  BedTyme, a sleep coaching app for iOS and Android offering 1:1 text based coaching. - Zoom based 1:1 coaching with Coach Michelle or Coach Daniel. The Insomnia Immunity program is perfect if you like learning through video and want to join a group on your journey towards sleeping well. BedTyme is ideal if you like to learn via text and have a sleep coach in your pocket. The 1:1 Zoom based program is for you if you like to connect one on one with someone who has been where you are now. Find out more about these programs here: https://www.thesleepcoachschool.com/  Do you like learning by reading? If so, here are two books that offer breakthroughs! Tales of Courage by Daniel Erichsen https://www.amazon.com/Tales-Courage-... Set it & Forget it by Daniel Erichsen https://www.amazon.com/Set-Forget-rea...  Would you like to become a Sleep Hero by supporting the Natto movement on Patreon? If so, that's incredibly nice of you

Xanax and other benzodiazepines (“benzos”) are often prescribed to treat symptoms like agitation, anxiety, and depression in people living with dementia. Yet, these drugs come with significant side effects and safety concerns, especially for older adults living with dementia. The Women's Age Lab's Dr. Paula Rochon and Dr. Christina Reppas-Rindlisbacher join Being Patient Live Talks to discuss why these medications are prescribed and what treatment alternatives they recommend. Rochon is the founding director of Women's Age Lab, a geriatrician, and a senior scientist at Women's College Hospital and ICES. She chairs the Canadian Institutes for Health Research Institute of Aging Advisory Board to support research and promote healthy aging across Canada. Rochon is committed to the development of trainees and new investigators in aging research and making valuable contributions to our future understanding of aging. Her team has won prestigious research awards, and published in peer-reviewed academic journals, disseminating key learnings and important findings from their research projects. Reppas-Rindlisbacher is a trainee with the Women's Age Lab at the Women's College Research Institute. She currently works as a geriatrician whilst completing her PhD in Clinical Epidemiology & Health Care Research at the Institute of Health Policy, Management and Evaluation (IHPME) at the University of Toronto. Her research aims to better understand how delirium care differs depending on sociodemographic factors such as gender, income, language, and recent immigrant status. Watch this live talk to learn more about benzodiazepines, why they are prescribed, and alternative treatments for people living with dementia. Read the Article: https://www.beingpatient.com/benzodiazepines-and-dementia/ ___ If you loved watching this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/

What are benzodiazepines? How are they used? What are the risks? Benzodiazepines can feel like a miracle for a person with anxiety. Feeling panicked to feeling ok in a matter of minutes. But there's more to them than that.  Tune in to this week's episode of All Things Substance.

Meet Dr. Doryn Chervin. Hear her benzo story. Her background in public health. Her take on benzos, BIND, setbacks, research, doctors, healing, the benzo community, and what has been going on behind the scenes at Easing Anxiety. Doryn Chervin holds a doctorate in public health and spent 40 years as a public health program strategist and evaluator. She is also on the board at the Alliance for Benzodiazepine Best Practices. Doryn took clonazepam for over 25 years, is now benzo-free, and works tirelessly helping those still struggling with dependence and BIND.Video ID: BFP128 CHAPTERS00:00 INTRODUCTION02:10 Welcome Doryn02:38 Doryn's Background04:38 Suicide Prevention Leadership06:15 Doryn's Benzo Story09:13 It's Really Possible to Heal 09:42 How Are You Feeling Now? 11:01 BIND Setbacks12:38 Journey to Learn / FDA 13:33 Doryn and the Alliance 14:57 FDA / Kaiser Research Study17:43 Working Together at EA 19:38  Partnering with the Community 21:42 Anxiety and Instability 22:59 There's No One Way25:32 Murphy Says Hi26:28 Upcoming Podcast on EA Plan27:10 Financial Sustainability 30:53 Getting to Know Doryn 31:55 Content & Services 34:56 An Information Resource35:55 A Strong Research Background39:26 The Human Connection43:03 We Want to Hear from You46:57 Sub Group Peer Support49:21 Live / In-Person Events51:00 Falling Asleep to the Podcast52:04 Burnout in Benzo Community54:02 EA Updates / Next Podcast55:25 Doryn's Struggle with Anxiety57:04 CLOSING    REFERENCESFeedback—    What Do You Want to See at Easing Anxiety? — https://easinganxiety.com/feedbackResources—    Doryn's Introductory Blog Post — https://www.easinganxiety.com/post/introducing-dr-doryn-chervin —    The Alliance for Benzodiazepine Best Practices — https://benzoreform.org  —    The National Action Alliance for Suicide Prevention — https://theactionalliance.org —    FDA 2020 Boxed Warning on Benzodiazepines https://www.easinganxiety.com/post/new-fda-warning-on-benzodiazepines-what-does-it-really-mean —    The Ashton Manual — https://easinganxiety.com/ashton —    BOOK: Benzo Free: The World of Anti-Anxiety Drugs and the Reality of Withdrawal — https://easinganxiety.com/book  —    Benzodiazepine Action Work Group — https://benzoaction.org—    A Peacock Consulting (Angela Peacock) — https://apeacockconsulting.com  SITE LINKSVISIT US ONLINE — Website: https://www.easinganxiety.com — YouTube: https://youtube.com/@easinganx — Twitter: https://twitter.com/@easinganx — Facebook: https://facebook.com/easinganxfb — Instagram: https://instagram.com/easinganx SUBSCRIBE / SUPPORT US — Join Our Mailing List: https://easinganxiety.com/subscribe — Make a Donation: https://easinganxiety.com/donate  PODCAST SUMMARYThis podcast is dedicated to those who struggle with side effects, dependence, and withdrawal from benzos, a group of drugs from the benzodiazepine and nonbenzodiazepine classes, better known as anti-anxiety drugs, sleeping pills, sedatives, and minor tranquilizers. Their common brand names include Ambien, Ativan, Klonopin, Lunesta, Valium, and Xanax. DISCLAIMERAll content provided on this YouTube channel is for general informational purposes only and should never be considered medical or health advice. The author of the content provided on this channel is not engaged in rendering medical, health, psychological, or any other kind of personal or professional services. Health-related information provided is not a substitute for medical advice and should not be used to diagnose or treat health problems or to prescribe any medical devices or other remedies. Never disregard medical advice or delay in seeking it.Please visit our website for our complete disclaimer at https://www.easinganxiety.com/disclaimer.  MUSIC CREDITS— All music provided / licensed through Storyblocks (https://www.storyblocks.com)  Benzo Free Theme— Title: "Walk in the Park" — Artist: Neil Cross PRODUCTION CREDITSEasing Anxiety is produced by…Denim Mountain Press https://www.denimmountainpress.com

Dr Feigin discusses findings from a study on the varying effects of the benzodiazepines lorazepam and alprazolam on PFS outcomes for patients with pancreatic cancer.

Nari Hsiu, D.O., psychiatry and addiction medicine specialist at the Boise VA Medical Center presents a lecture on "Tapering Off Benzodiazepines: the How and Why."

2023 SAEM PharmD Research  02:10 – Emergency Medicine Resident Perceptions of the Educational Impact of Emergency Medicine Clinical Pharmacists with Francisco Ibarra, PharmD, BCCCP 12:10 – Impact of Emergency Medicine Pharmacists on Anticoagulation Reversal with Jaclyn Scalgione, PharmD, BCPS 24:25 – Incidence of Postintubation Hypotension after Rapid Sequence Intubation in Full vs. Reduced Dose Induction Agent with Alicia Mattson, PharmD, BCCCP 35:12 – Phenobarbital as an Adjunct to Benzodiazepines in the Setting of Alcohol Withdrawal with Amelia Slane, PharmD, BCPS 48:19 – Single Dose Aminoglycosides for Complicated Urinary Tract Infections in the Emergency Department with Jordan Jenrette, PharmD 61:53 – Effect of Intravenous vs. Oral First Dose Antibiotics in the Emergency Department on Hospital Admission with Jessica Pham, PharmD PharmacyToDose.Com  @PharmacyToDose  PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices

For those of you who missed it, Jared gave a well-received talk at Be Healthy Utah on April 22nd in Utah. Many people asked for a copy of that talk, so he decided to reproduce it as a podcast. This isn't that talk, it is new, but it covers the same territory in even more detail.Mental Health is a mounting issue in America today.  Pharma prescriptions are higher than ever before, more people are in therapy than ever before and more than ever, people are searching for alternatives to those methods. In today's episode, Jared runs through what he considers to be the foundational things that you should consider to improve your mental health.  You will learn about the gut-brain connection, deficiencies that impact mental health, the value of breath, sleep, water,  sunshine, and more.Products:Precision Probiotic Vital SporesVital 5 Magnesium BisglycinateVital 5 Ultimate Vitality Multi-VitaminBioCoenzymated Active B ComplexVital 5 Omega 3 + AntioxidantsUltra Strength RX Omega 3Sensoril AshwagandhaAnxiety ReleaseVital SleepL-Theanine chewables Additional Information:Episode #164: Psychobiotics - Unique Probiotics for Depression, Anxiety and More Part 1Episode #166: Psychobiotics - Unique Probiotics for Depression Anxiety and More Part 2Episode #306: The Great Debate in Probiotics: Human Strains vs. SporesEpisode #258: Your Magnesium Users GuideEpisode #264: Jen's Story: How One Woman Fought Through Addiction, Mental and Physical Illness to Find Vitality.Episode #265: Sleep! Your Guide to Falling Asleep, Staying Asleep and Deeper and More Restful SleepTickets to the Mitten Durch Mental Health FestivalOgdenite ArticleVisit the podcast website here: VitalityRadio.comYou can follow @vitalityradio and @vitalitynutritionbountiful on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.